HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of the combination with alpha-tricalcium phosphate and simvastatin on bone regeneration.

AbstractBACKGROUND:
Although local application of statins stimulates bone formation, high dose of simvastatin induces inflammation.
OBJECTIVE:
A study was conducted to test the hypothesis that maximum bone regeneration with less inflammation would be achieved by combining an optimal dose of simvastatin with alpha-tricalcium phosphate (alpha-TCP), which is an osteoconductive biomaterial capable of releasing the drug gradually.
MATERIAL AND METHODS:
Bilateral 5-mm-diameter calvarial defects were created in adult Wistar rats and filled with preparations of different doses of simvastatin (0, 0.01, 0.1, 0.25 and 0.5 mg) combined with alpha-TCP particles or left empty. The animals were sacrificed at 2, 4 and 8 weeks and analyzed radiologically and histologically. Half of the animals of 4 and 8 weeks were labeled with fluorescence dyes and histomorphometrically analyzed.
RESULTS:
Simvastatin doses of 0.25 and 0.5 mg caused inflammation of the soft tissue at the graft site whereas control and other doses did not. The micro-CT analysis revealed that the alpha-TCP with 0.1 mg simvastatin (TCP-0.1) group yielded significantly higher bone volumes than untreated control group at all three time points (249%, 227% and 266% at 2, 4 and 8 weeks, respectively). The percentage of defect closure, bone mineral content and bone mineral density were also higher in the TCP-0.1 group than in the other groups.
CONCLUSION:
When combined with alpha-TCP particles, 0.1 mg simvastatin is the optimal dose for stimulation of the maximum bone regeneration in rat calvarial defects without inducing inflammation and it could be applied as an effective bone graft material.
AuthorsMyat Nyan, Daisuke Sato, Hidemichi Kihara, Tetsu Machida, Keiichi Ohya, Shohei Kasugai
JournalClinical oral implants research (Clin Oral Implants Res) Vol. 20 Issue 3 Pg. 280-7 (Mar 2009) ISSN: 1600-0501 [Electronic] Denmark
PMID19397639 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticholesteremic Agents
  • Biocompatible Materials
  • Calcium Phosphates
  • Drug Carriers
  • Drug Combinations
  • alpha-tricalcium phosphate
  • Simvastatin
Topics
  • Analysis of Variance
  • Animals
  • Anticholesteremic Agents (pharmacology)
  • Biocompatible Materials (pharmacology)
  • Bone Regeneration (drug effects)
  • Calcium Phosphates (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Carriers (pharmacology)
  • Drug Combinations
  • Osteogenesis (drug effects)
  • Rats
  • Rats, Wistar
  • Simvastatin (pharmacology)
  • Skull (drug effects, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: